Ontrak (OTRK) Stock Price, News & Analysis

Company Overview

Ontrak, Inc. (NASDAQ:OTRK) is a technology-enabled behavioral health company that delivers whole-person care to individuals with complex chronic conditions. Through a combination of proprietary data analytics and digital engagement tools, the company identifies members with care gaps in areas such as depression, anxiety, substance use disorder and chronic diseases like diabetes and heart disease. Once engaged, participants are enrolled in virtual care programs guided by a network of licensed clinicians and care coaches who provide personalized support and remote patient monitoring.

The company’s core offering integrates telehealth consultations, 24/7 support lines and connected health devices with evidence-based coaching to drive adherence to medical treatment plans. Ontrak partners with health plans, employers and provider groups on a value-based model, aligning reimbursement with measurable improvements in health outcomes. Its data-driven outreach and performance-based structure aim to reduce hospitalizations, emergency department visits and total cost of care.

Founded in 1988 as Holistic, Inc., the company rebranded to Ontrak in 2020 to reflect its focus on proactive, technology-driven interventions. Headquartered in Irvine, California, Ontrak serves commercially insured, Medicare and Medicaid populations across the United States. The company leverages machine learning algorithms and predictive modeling to continuously refine its outreach strategies and adapt care protocols to each participant’s evolving needs.

Key Stats

• Today's Range: $0.02 to $0.03
• 50-Day Range: $0.01 to $0.44
• 52-Week Range: $0.05 to $0.12
• Volume: 12,218 shs
• Average Volume: 268,028 shs
• Market Capitalization: $92.80 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.00
• Consensus Rating: Buy

Ontrak Stock Analysis - MarketRank™

Ontrak scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Ontrak has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

Ontrak has a consensus price target of $3.00, representing about 13,536.4% upside from its current price of $0.02.

Amount of Analyst Coverage

Ontrak has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Ontrak are expected to grow in the coming year, from ($7.53) to ($4.05) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Ontrak is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ontrak is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Ontrak has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for OTRK.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ontrak does not currently pay a dividend.

Dividend Growth

Ontrak does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for OTRK.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

10 people have searched for OTRK on MarketBeat in the last 30 days. This is an increase of 900% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Ontrak to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ontrak insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.90% of the stock of Ontrak is held by insiders.

Percentage Held by Institutions

Only 12.95% of the stock of Ontrak is held by institutions.

OTRK Stock Analysis - Frequently Asked Questions

How have OTRK shares performed this year?

Ontrak's stock was trading at $1.79 at the beginning of 2025. Since then, OTRK shares have decreased by 98.8% and is now trading at $0.0220.

How were Ontrak's earnings last quarter?

Ontrak, Inc. (NASDAQ:OTRK) announced its quarterly earnings data on Tuesday, May, 20th. The company reported ($1.65) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.24) by $0.41. The business had revenue of $2.02 million for the quarter. Ontrak had a negative net margin of 274.20% and a negative trailing twelve-month return on equity of 269.88%.
Read the conference call transcript.

When did Ontrak's stock split?

Ontrak shares reverse split on the morning of Monday, September 23rd 2024.The 1-15 reverse split was announced on Thursday, September 19th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

How do I buy shares of Ontrak?

Shares of OTRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Ontrak own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ontrak investors own include Enovix (ENVX), Globant (GLOB), Luminar Technologies (LAZR), Rambus (RMBS), COMPASS Pathways (CMPS), Ginkgo Bioworks (DNA) and Toast (TOST).

Company Calendar

• Last Earnings: 5/20/2025
• Today: 10/20/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:OTRK
• CIK: 1136174
• Web: ontrakhealth.com
• Phone: (310) 444-4300
• Fax: 888-975-7712
• Employees: 250
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Ontrak: $3.00
• High Price Target: $3.00
• Low Price Target: $3.00
• Potential Upside/Downside: +13,536.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($15.81)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$25.49 million
• Net Margins: -274.20%
• Pretax Margin: -274.20%
• Return on Equity: -269.88%
• Return on Assets: -128.35%

Debt

• Debt-to-Equity Ratio: 0.54
• Current Ratio: 0.72
• Quick Ratio: 0.72

Sales & Book Value

• Annual Sales: $10.18 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.34 per share
• Price / Book: 0.01

Miscellaneous

• Outstanding Shares: 4,218,000
• Free Float: 4,138,000
• Market Cap: $92.80 thousand
• Optionable: No Data
• Beta: 1.97